Ask VialBase
hormone

Triptorelin

FDA: FDA-approved

Triptorelin is a GnRH agonist that reduces sex hormone levels through receptor desensitization. In peptide biohacking, it is used as a short-term HPTA restart tool, functioning as an alternative to Buserelin for jumpstarting suppressed testosterone production. GnRH agonist that desensitizes the pituitary to reduce LH and FSH secretion, suppressing sex hormone production. The initial surge before suppression can be harnessed for short-term HPTA reboot. Used to treat hormone-sensitive cancers, endometriosis, and as part of fertility protocols. - HPTA reboot and testosterone restoration after suppression - Short-term LH/FSH jumpstart - Alternative to Buserelin for post-TRT/steroid recovery - HPTA restart: Single dose

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —
02

Sourcing

Current prices

Updated today

2mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • LH
  • FSH
  • Testosterone (Total + Free)
  • Estradiol
  • CMP
  • CBC
DURING CYCLE
  • LH
  • FSH
  • Testosterone
  • Estradiol
POST-CYCLE
  • LH
  • FSH
  • Testosterone
  • Estradiol
  • CMP
Safety & Regulatory Status
FDA STATUS FDA-approved

Regulatory status for Triptorelin may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.